Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Managing common endocrine disorders amid COVID-19 pandemic.

Tytuł :
Managing common endocrine disorders amid COVID-19 pandemic.
Autorzy :
Pal R; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Bhadada SK; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India. Electronic address: .
Pokaż więcej
Źródło :
Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2020 Sep - Oct; Vol. 14 (5), pp. 767-771. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Journal Article; Review
Język :
Imprint Name(s) :
Original Publication: Amsterdam : Elsevier Ltd.
MeSH Terms :
Coronavirus Infections/*epidemiology
Endocrine System Diseases/*therapy
Pneumonia, Viral/*epidemiology
Betacoronavirus/physiology ; Coronavirus Infections/complications ; Endocrine System Diseases/complications ; Endocrine System Diseases/epidemiology ; Endocrinology/organization & administration ; Endocrinology/trends ; Humans ; Pneumonia, Viral/complications ; Practice Guidelines as Topic
Contributed Indexing :
Keywords: COVID-19; Calcium-related disorders; Cushing’s syndrome; Diabetes mellitus; Endocrine disorders; Osteoporosis; Pituitary tumors; Primary adrenal insufficiency
SCR Disease Name :
Entry Date(s) :
Date Created: 20200611 Date Completed: 20200924 Latest Revision: 20200924
Update Code :
PubMed Central ID :
Czasopismo naukowe
Background and Aims: The novel coronavirus disease (COVID-19) pandemic and the resulting nationwide lockdowns have posed a major challenge to the management of pre-existing and newly diagnosed endocrine disorders. Herein, we have summarized the management approaches of common endocrine disorders amid the ongoing pandemic.
Methods: We have performed an extensive literature search for articles in PubMed, EMBASE and Google Scholar databases till 25 May 2020, with the following keywords: "COVID-19", "diabetes mellitus", "thyroid disorders", "primary adrenal insufficiency", "Cushing's syndrome", "pituitary tumors", "vitamin D″", "osteoporosis", "primary hyperparathyroidism", "hypoparathyroidism", "management", "treatment" and "guidelines" with interposition of the Boolean operator "AND".
Results: We have summarized the most feasible strategies for the management of diabetes mellitus, thyroid disorders, primary adrenal insufficiency (including congenital adrenal hyperplasia), Cushing's syndrome, pituitary tumors, osteoporosis, primary hyperparathyroidism and hypoparathyroidism amid the constraints laid down by the raging pandemic. In general, medical management should be encouraged and surgical interventions should be deferred whenever possible. Ongoing medications should be continued. Sick-day rules should be sincerely adhered to. Regular contact with physicians can be maintained through teleconsultations and virtual clinics.
Conclusions: Considering the burden of endocrine disorders in the general population, their management needs to be prioritized amid the ongoing COVID-19 pandemic.
(Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies